Showing 1 - 10 of 1,917
Persistent link: https://www.econbiz.de/10003942716
Persistent link: https://www.econbiz.de/10012586698
Persistent link: https://www.econbiz.de/10012586735
Methods: A decision tree model was built with life years gained as outcome, from the perspective of the health system, and including all direct costs. Pharmaceutical prices were obtained from the System of Information of Medicaments SISMED (2008), and the value of procedures was calculated from...
Persistent link: https://www.econbiz.de/10013089226
Objetive: To assess the cost effectiveness of unrelated stem cell transplantation versus consolidation chemotherapy in pediatric population with high-risk acute myeloid leukemia (AML).Methods: A decision tree model was built with life years gained as outcome, from the perspective of the health...
Persistent link: https://www.econbiz.de/10013089227
Markov-based and discrete event simulation models are widely used in health economic analysis to estimate the long term effects of treatment on clinical and economic outcomes. However, none of them simultaneously integrate patients' economic resources and their medical decision making in the...
Persistent link: https://www.econbiz.de/10012982762
Persistent link: https://www.econbiz.de/10011869543
Persistent link: https://www.econbiz.de/10011948237
Comparative effective research (CER) compares alternative methods of preventing, diagnosing, treating, and otherwise managing medical conditions. The Patient Protection and Affordable Care Act authorized creation and funding of an independent agency, the Patient-Centered Outcomes Research...
Persistent link: https://www.econbiz.de/10014043734
Persistent link: https://www.econbiz.de/10009355005